China Medical & HealthCare Group Limited provided earnings guidance for the year ended December 31, 2020. For the period, the group expects to record a loss attributable to shareholders of the company in the range of approximately HKD 100 million to HKD 170 million (subject to any further impairment or other adjustments) as compared with a net profit of approximately HKD 2.2 million for the corresponding period in 2019 (eighteen months). This was mainly due to the adverse factors set out in the profit warning announcement and further to the loss on fair value changes on investment properties compared with a gain recorded in the corresponding period in 2019 (eighteen months); and additional increase in impairment loss under expected credit loss model of financial assets.